IL6 and neoplasm: RT-qPCR analysis demonstrated upregulation of anti-tumor inflammatory cytokines (IL-6, TNF-α, iNOS) and concurrent downregulation of pro-tumor factors (IL-4, IL-10) (Fig. 6C), confirming successful M2 to M1 phenotype conversion with efficacy comparable to LPS treatment.